RNA-seq quality assessment
1
0
Entering edit mode
7.0 years ago
amy16 ▴ 40

I've completed mapping the RNA-seq to the reference genome using HISAT2. Now I would like to assess the quality of the samples. What is the recommended tool to do it? PS: I am only a beginner.

RNA-Seq • 2.3k views
ADD COMMENT
0
Entering edit mode

RNA-SeQC for one. What do alignment stats look like?

ADD REPLY
0
Entering edit mode

HISAT2 summary stats:

   Total pairs: 30462111
            Aligned concordantly or discordantly 0 time: 1887598 (6.20%)
            Aligned concordantly 1 time: 24214657 (79.49%)
            Aligned concordantly >1 times: 1792176 (5.88%)
            Aligned discordantly 1 time: 2567680 (8.43%)
    Total unpaired reads: 3775196
            Aligned 0 time: 1903554 (50.42%)
            Aligned 1 time: 1501779 (39.78%)
            Aligned >1 times: 369863 (9.80%)
    Overall alignment rate: 96.88%
  
ADD REPLY
2
Entering edit mode
7.0 years ago
mforde84 ★ 1.4k

FastQC is good for both pre- and post- alignment QC. Picard tools has a bunch of QC related tools you can use. For starters, I'd first look at the % of uniquely mapped reads to get a general idea of how well your sequences aligned to the reference. For human cell lines, a good alignment will be 50%+. Paraffin embedded tissue or other similar preparation methods will likely have more degradation so I'd assume that the alignments might suffer a bit. QC will typically assess the sequencing quality (how well the sequencer sequenced what you gave it to sequence), and not necessarily the quality of the material you gave the sequencer to sequence.

ADD COMMENT
0
Entering edit mode

Ok. I would like to use Picard tools. I have the gene annotation file in GFF3 format. How do I convert it to REF_FLAT (File) format?

ADD REPLY
0
Entering edit mode

Any possible reference for the statement "For human cell lines, a good alignment will be 50%+. ".

ADD REPLY

Login before adding your answer.

Traffic: 1698 users visited in the last hour
Help About
FAQ
Access RSS
API
Stats

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6